23. Juni 2018 | Legal
USA. Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy’s Launch “At-Risk”
USA. Indivior Responds to Generic SUBOXONE® Approvals and Dr. Reddy’s Launch “At-Risk”
Indivior PLC (LON: INDV) (“Indivior” or the “Company”) today announced that it is aware that, on 14 June 2018, the…